the market?
Peregrine Pharmaceuticals
NASDAQ: PPHM
1.70
0.08
(4.94%)
| Today's Open | $1.70 |
|---|---|
| Previous Close | $1.62 |
| Daily Range | $1.64 - $1.73 |
| 52-Week Range | $0.42 - $5.50 |
| Market Cap | $233.1M |
| P/E Ratio | -5.59 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 4,783,609 |
| Average Daily Volume | 2,663,243 |
| Current FY EPS | -$0.23 |
How do you think PPHM
will perform against the market?
Top PPHM Bull/Bear Pitches
News & Commentary
FDA Green Light = Surprise Share Surge
Did this FDA decision really justify a big stock pop?These Winners Couldn't Send the Dow to Another Record
The Dow fell slightly, but several stocks posted solid gains.Biotech Companies: The FDA Doesn't Care About Your Phase 3 Trials
Results? Yes. Starting them? Not so much.Why Peregrine Pharmaceuticals Shares Skyrocketed
An A-OK from the FDA sends Peregrine shares to the moon!Is Peregrine Preparing to Soar Again?
The company completes enrollment for a bavituximab breast cancer trial.3 Stocks That Blew the Market Away
These three companies posted better than expected results on the bottom line.February's Biggest Biotech Loser Bounces Back
Peregrine's roller coaster ride is as exciting for investors as it is nauseating.5 Reasons Not to Worry This Week
These five companies are posting year-over-year improvements on the bottom line.Peregrine Pharmaceuticals Earnings: An Early Look
Let's look forward to this company's next earnings report.Sector
Healthcare
Industry
Drugs
Peregrine Pharmaceuticals (PPHM) Description
A biopharmaceutical company with a portfolio of clinical stage and pre-clinical product candidates using monoclonal antibodies for the treatment of cancer and viral diseases. Website: http://www.peregrineinc.com/
CEO Rating by Glassdoor
More details for Peregrine Pharmaceuticals Jobs
Peregrine Pharmaceuticals reviews from employees
